Emerging Growth Capital Flows Analysis

Venture: Wrap This Week in Tweets - Dec 09, 2022

IQ500 — Fri, 09 Dec 2022 09:46:55 GMT

This week in Venture Wrap...

2022 sees twice the PE M&A of public software companies as compared to 2021
Temasek & Blackrock partner launch a new decarbonization VC/PE firm
Stats around cleantech/nuclear tech
Other exciting reads/listens

Software: Follow the Money

IQ500 — Wed, 28 Sep 2022 09:11:51 GMT

It is hard to disagree that 2021 was an unprecedented year for capital markets. Every risk asset was hot, from SPACs, and M&A, to the private market. One place capital, and attention, flocked to was growth technology. VC investments in Software would fit that description, and the numbers speak for themselves.

Biotech: Hiding in Plain Sight

IQ500 — Wed, 28 Sep 2022 09:11:22 GMT

Biotechnology investments globally have seen a strong shift towards Asia. The devil's in the detail, however, regarding the key driver for the shift.

Biotech: Forever Young

IQ500 — Fri, 19 Aug 2022 05:56:50 GMT

Over recent years, venture investments in Biotech have been substantial; that is no secret. Perhaps what may not be as widely observed is how those investments have changed in the company stage over the years. It would appear that money is moving toward more mature companies.